SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-020171
Filing Date
2017-12-05
Accepted
2017-12-05 13:04:10
Documents
8
Period of Report
2017-11-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cenb20171204_8k.htm 8-K 31224
2 EXHIBIT 10.1 ex_101405.htm EX-10.1 77056
3 EXHIBIT 10.2 ex_101406.htm EX-10.2 75863
4 EXHIBIT 10.3 ex_101407.htm EX-10.3 76907
5 EXHIBIT 10.4 ex_101408.htm EX-10.4 75917
6 EXHIBIT 10.5 ex_101409.htm EX-10.5 102471
7 EXHIBIT 10.6 ex_101410.htm EX-10.6 38717
8 EXHIBIT 10.7 ex_101411.htm EX-10.7 39552
  Complete submission text file 0001437749-17-020171.txt   518880
Mailing Address 20 N REAR RD LAKESHORE A6 N0R 1A0
Business Address 20 N REAR RD LAKESHORE A6 N0R 1A0 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55557 | Film No.: 171239198
SIC: 2834 Pharmaceutical Preparations